#541: Lean Mass Hyper Responders & the Lipid Energy Model: Do the Claims Stand Up to Scrutiny?

Listen Here:

Click or simply search “Sigma Nutrition” on your podcast platform of choice.

Or listen directly on the Sigma website here.

Introduction

When discussing cardiovascular health, few topics stir as much debate as cholesterol, particularly in relation to low-carb and ketogenic diets. Recently, there’s been significant attention given to a proposed model that suggests high LDL cholesterol may not pose the same cardiovascular risk in certain individuals, specifically those labeled as “lean mass hyper-responders.” This raises important questions: Is it possible that high cholesterol might not be dangerous for everyone? Or are we witnessing a dangerous misinterpretation of the science?

In this episode, we break down the ideas behind the “lipid energy model” and explore how it has been framed in the context of low-carbohydrate and ketogenic diets. While proponents claim this model sheds light on how some people can have elevated LDL without increasing heart disease risk, critics warn that miscommunication and oversimplification of these ideas are leading many down a dangerous path. With real-world health decisions hanging in the balance, it’s crucial to carefully examine what the science truly says about cholesterol, inflammation, and heart disease.

Join us as we dive into the evidence with Dr. Gary McGowan. We’ll dissect what the current research supports, what remains speculative, and how social media has amplified both the promising and problematic aspects of this model. If you’ve ever wondered about the impact of high cholesterol on heart disease risk in the context of ketogenic or low-carb diets, this episode is essential listening.

Related resources

Timestamps

Guest Information

Click through to your app of choice to listen and subscribe:

Previous to his medical training, Dr. McGowan did an undergraduate degree in physiotherapy. He is also a certified personal trainer.

He is currently completing a MSc. in Preventative Cardiology from the University of Galway. He is the founder of Triage Method, a company that provides health and fitness coaching.

Gary McGowan, MB BCh BAO Medicine
a medical doctor, graduating from University College Cork, Ireland with a MB BCh BAO in Medicine.

Danny Lennon has a master’s degree (MSc.) in Nutritional Sciences from University College Cork, and he is the founder of Sigma Nutrition.

Danny is currently a member of the Advisory Board of the Sports Nutrition Association, the global regulatory body responsible for the standardisation of best practice in the sports nutrition profession.

Danny Lennon
MSc. in Nutritional Sciences from University College Cork

Introduction to this Episode

When discussing cardiovascular health, few topics stir as much debate as cholesterol, particularly in relation to low-carb and ketogenic diets. Recently, thereʼs been significant attention given to a proposed model that suggests high LDL cholesterol may not pose the same cardiovascular risk in certain individuals, specifically those labeled as “lean mass hyper-responders.” This raises important questions: Is it possible that high cholesterol might not be dangerous for everyone? Or are we witnessing a dangerous misinterpretation of science?

In this episode, we break down the ideas behind the “lipid energy model” and explore how it has been framed in the context of low-carbohydrate and ketogenic diets. While proponents claim this model sheds light on how some people can have elevated LDL without increasing heart disease risk, critics warn that miscommunication and oversimplification of these ideas are leading many down a dangerous path. With real-world health decisions hanging in the balance, itʼs crucial to carefully examine what the science truly says about cholesterol, inflammation, and heart disease.

Join us as we dive into the evidence with Dr. Gary McGowan. Weʼll dissect what the current research supports, what remains speculative, and how social media has amplified both the promising and problematic aspects of this model. If youʼve ever wondered about the impact of high cholesterol on heart disease risk in the context of ketogenic or low-carb diets, this episode is essential listening.

Useful Terminology for this Episode

Key Terms & Acronyms
  • Triglycerides: Triglycerides are a type of lipid present in the bloodstream and serve as the bodyʼs main form of stored fat. Structurally, triglycerides consist of three fatty acids attached to a glycerol backbone. Elevated triglyceride levels can be associated with cardiovascular risk, particularly in the context of other metabolic conditions.
  • Very Low-Density Lipoprotein (VLDL): VLDL is a lipoprotein synthesized by the liver and primarily responsible for transporting triglycerides through the bloodstream to various tissues. During circulation, VLDL releases triglycerides, eventually transforming into low-density lipoprotein (LDL) particles. Elevated VLDL levels are linked to an increased risk of cardiovascular disease.
  • Low-Density Lipoprotein (LDL): A lipoprotein that transports cholesterol from the liver to cells throughout the body. High LDL levels can lead to cholesterol buildup in the arteries, increasing the risk of atherosclerosis, heart attack, and stroke. Monitoring and managing LDL levels is a crucial aspect of cardiovascular risk assessment.
  • High-Density Lipoprotein (HDL): HDL is a lipoprotein that helps remove excess cholesterol from the bloodstream, transporting it back to the liver for elimination. Higher levels of HDL are generally associated with a lower risk of cardiovascular disease.
  • Lipoprotein Lipase (LPL): Lipoprotein lipase (LPL) is an enzyme that facilitates the breakdown of triglycerides within lipoproteins, such as VLDL, converting them into free fatty acids that cells can utilize for energy. LPL activity also aids in the conversion of VLDL to LDL particles, influencing overall lipid levels in the bloodstream and impacting lipid metabolism.
  • Apolipoprotein B (ApoB): ApoB is a key protein component of atherogenic lipoproteins, including LDL, VLDL, and intermediate-density lipoproteins (IDL), and is essential for their structure and function. ApoB measurement provides an estimate of the number of atherogenic particles in the blood, serving as a valuable marker for cardiovascular risk assessment.
  • Coronary Artery Calcium (CAC) Score: The CAC score quantifies calcium buildup in the coronary arteries using computed tomography (CT) imaging, serving as an indirect marker of atherosclerosis. Higher CAC scores indicate more extensive calcification and correlate with increased cardiovascular disease risk.

 

Premium Content

You are currently not signed-in as a Premium subscriber.

To view our Premium content, please log-in to your account or subscribe to Premium.

Explore

Unlock the Power of Sigma Nutrition with Premium

Significantly deepen your understanding of nutrition science and become truly confident in your knowledge.